JAMA Network Home
Sign In
Research Letter

Using the PREVENT Equations to Guide Aspirin Use for Primary Prevention of Cardiovascular Disease

JAMA Internal Medicine 10.1001/jamainternmed.2025.5049

September 29, 2025 at 11:00 AM EDT

Read the full article

This cross-sectional study examines eligibility for aspirin for the primary prevention of cardiovascular disease based on the pooled cohort equations and the Predicting Risk of Cardiovascular Disease EVENTs equations.

Corresponding Author: Ann Marie Navar, MD, PhD, Department of Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, E5.722, Dallas, TX 75390 (ann.navar@utsouthwestern.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2025.5049?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=092925

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks